What is the recommended treatment for trichomoniasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Trichomoniasis

The recommended first-line treatment for trichomoniasis is metronidazole 500 mg orally twice daily for 7 days, which achieves superior cure rates of 90-95% compared to single-dose therapy. 1, 2, 3

Primary Treatment Regimen

  • Metronidazole 500 mg orally twice daily for 7 days is the preferred regimen based on the most recent CDC guidelines and high-quality randomized controlled trial evidence showing better efficacy than single-dose therapy. 1, 2, 3

  • A 2018 randomized controlled trial of 623 women demonstrated that 7-day dosing resulted in significantly fewer treatment failures (11%) compared to single-dose therapy (19%), with a relative risk of 0.55 (p<0.0001). 4

  • Alternative regimen: Metronidazole 2 g orally as a single dose can be used when adherence to multi-day therapy is a concern, though it has lower efficacy. 5

  • Tinidazole 2 g orally as a single dose is FDA-approved and equally effective as single-dose metronidazole (95-97% cure rates), offering an alternative for patients who cannot tolerate metronidazole. 6, 7

Critical Management Principles

  • All sexual partners must be treated simultaneously to prevent reinfection, which is the most common cause of treatment failure. 1, 2, 3

  • Patients must abstain from sexual activity until both partners complete treatment and are asymptomatic. 1, 2, 3

  • Advise patients to avoid alcohol during treatment and for at least 24 hours after completion due to risk of disulfiram-like reaction (nausea, vomiting, flushing, abdominal cramps). 1

What NOT to Do

  • Never use topical metronidazole gel for trichomoniasis - it has <50% efficacy because it fails to achieve therapeutic levels in the urethra and perivaginal glands where the organism resides. 5, 3, 8

Treatment Failure Algorithm

  • First treatment failure: Re-treat with metronidazole 500 mg twice daily for 7 days. 1, 2, 3

  • Second treatment failure: Administer metronidazole 2 g once daily for 3-5 days. 5, 1, 2

  • Persistent failure after excluding reinfection: Consult infectious disease specialist for possible resistant strains. 2, 3

Special Populations

Pregnancy

  • Metronidazole is contraindicated in the first trimester. 2, 3

  • After the first trimester, use metronidazole 2 g orally as a single dose (lower fetal exposure preferred). 2, 3

  • Treatment is important as trichomoniasis is associated with premature rupture of membranes and preterm delivery. 5, 2

HIV-Infected Patients

  • Use the same treatment regimens as HIV-negative patients - no modification needed. 5, 1, 2

Metronidazole Allergy

  • For true immediate-type allergy, desensitization may be required as effective alternatives are extremely limited. 2

  • Patients with intolerance (not true allergy) to oral metronidazole should not be given vaginal metronidazole as it is ineffective. 5

Follow-Up

  • Routine follow-up is unnecessary for patients who become asymptomatic after treatment. 1, 2, 3

  • Re-evaluate only if symptoms persist, considering reinfection (most common) or resistant infection. 2, 3

References

Guideline

Trichomonas Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Trichomoniasis Vaginal Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Trichomoniasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Single dose treatment of trichomoniasis.

The Journal of international medical research, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.